Approvals/TGA/KOZENIS tafenoquine 50 mg film-coated dispersible tablet blister pack

Approved

STANDARD

KOZENIS tafenoquine 50 mg film-coated dispersible tablet blister pack

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c4f019f958cfff2b
Product Name: KOZENIS tafenoquine 50 mg film-coated dispersible tablet blister pack
Artg Id: 350774
Artg Name: KOZENIS tafenoquine 50 mg film-coated dispersible tablet blister pack
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2022-03-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/663d2161d8bcea5e0bc790a0c8ef0dd7.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c4f019f958cfff2b

Type

Standard